“Last week, just over 15,000 deaths were reported to WHO — the lowest weekly total since March 2020,” Tedros Adhanom Ghebreyesus, PhD, director-general of the WHO, said during an April 26 press conference. “This is a very welcome trend, but it’s one that we should welcome with some caution,” he said, pointing to a lack of insight into transmission as many countries have relaxed testing.
“This makes us increasingly blind to patterns of transmission and evolution. But this virus won’t go away just because countries stop looking for it. It’s still spreading, it’s still changing and it’s still killing,” Dr. Tedros said. “WHO continues to call on all countries to maintain surveillance.”
The warning comes as the prevalence of BA.2.12.1 — a more transmissible sublineage of BA.2 — rises in the U.S., accounting for about 29 percent of cases for the week ending April 23, according to the CDC’s latest estimates. COVID-19 cases have increased about 61 percent nationwide over the past 14 days as of April 26, according to HHS data tracked by The New York Times.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
